Email
Password
Remember meForgot password?
    Log in with Twitter
Blog In Health

Prescription labelling issues

blog:20050:2::0
By Tim Sandle
Posted Jan 16, 2013 in Health
The U.S. Food and Drug Administration has published its monthly list of medicine labelling errors.
The medicines of concern are:
Altabax (Retapamulin)
Antara (Fenofibric Acid)
Celexa (Citalopram Hydrobromide)
Chantix (Varenicline)
Edurant (Rilpivirine)
Effexor (Venlafaxine Hydrochloride)
Effexor XR (Venlafaxine Hydrochloride)
Fibricor (Fenofibric Acid)
Horizant (Gabapentin Enacarbil)
Incivek (Telaprevir)
Lexapro ( Escitalopram Oxalate)
Omeprazole Sodium Bicarbonate and Magnesium Hydroxide
Omontys (Peginesatide)
Paxil (Paroxetine Hydrochloride)
Pexeva (Paroxetine Mesylate)
Pradaxa (Dabigatran Etexilate)
Pristiq (Desvenlafaxine)
Sabril (Vigabatrin)
Surmontil (Trimipramine Maleate)
Tamiflu (Oseltamivir Phosphate)
Venlafaxine
Viibryd (Vilazodone HCL)
Xyrem (Sodium Oxybate)
Zoloft (Sertraline Hydrochloride)
Zytiga (Abiraterone Acetate)
For more details, see the FDA Medwatch alert.

blog:20050:2::0
Latest News
Top News